PedAM
Pediatric Disease Annotations & Medicines
| Disease | nephrogenic systemic fibrosis |
| Phenotype | C0022658|renal disease |
| Sentences | 4 |
| PubMedID- 22070856 | The use of gadolinium in contrast-enhanced (ce) magnetic resonance angiography (mra) has been linked to nephrogenic systemic fibrosis in patients with end-stage renal disease (esrd). |
| PubMedID- 20721544 | Furthermore, ce-mra requires the use of gadolinium contrast agents, which carry the risk of allergic reactions and renal complications, including nephrogenic systemic fibrosis [10, 11] in patients with coexisting renal disease. |
| PubMedID- PMC3305254 | Given the abundance of fibrin in microthrombus, we have focused on developing gadolinium-free nanomedicine strategies for paramagnetic imaging of clot, respecting recent concerns regarding the pathological link between the lanthanide and nephrogenic systemic fibrosis in patients with severe renal disease. |
| PubMedID- 25875973 | Purpose: to determine the incidence of nephrogenic systemic fibrosis (nsf) in patients with renal disease who received gadobenate dimeglumine at a single medical center. |
Page: 1